Navigation Links
VIA Pharmaceuticals to Host Investor Science Briefing on the Role of Inflammation in Cardiovascular Disease on Tuesday, September 16
Date:9/9/2008

SAN FRANCISCO, Sept. 9 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that it will host a science briefing on Tuesday, September 16, 2008 at 12:00pm Eastern Time in New York City. Keynote speaker Dr. Peter Libby, Chief of Cardiovascular Medicine at the Brigham and Women's Hospital and Mallinckrodt Professor of Medicine at Harvard Medical School, will present "Inflammation in Atherosclerosis: Theory and Practice." Following Dr. Libby's presentation, Dr. Lawrence K. Cohen, chief executive officer of VIA Pharmaceuticals, will moderate an expert panel.

"We are pleased to have Dr. Libby speak about the importance of inflammation in atherosclerosis," said Lawrence K. Cohen, Ph.D., chief executive officer of VIA Pharmaceuticals. "While there are a number of currently available therapies that help reduce risk factors of heart disease, they do not address inflammation, an underlying cause of atherosclerosis and complications such as heart attack and stroke."

Dr. Libby is the Chief of Cardiovascular Medicine at the Brigham and Women's Hospital in Boston, Massachusetts and serves as the Mallinckrodt Professor of Medicine at Harvard Medical School. He also directs the D.W. Reynolds Cardiovascular Clinical Research Center at Harvard. His current major research focus is the role of inflammation in vascular diseases such as atherosclerosis. Dr. Libby has received numerous awards and recognitions for his research accomplishments. His areas of clinical expertise include general and preventive cardiology. Dr. Libby writes a cardiovascular blog, "Consults-Experts on the Front Lines of Medicine", for
'/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013 Northwest Biotherapeutics ... company developing DCVax ® personalized immune therapies for ... its exhibit at this year,s American Society Of Clinical ... to highlight its leadership role in immune therapy.  ... ASCO annual meeting is the pre-eminent conference focused on ...
(Date:5/23/2013)... May 23, 2013  Verenium Corporation (Nasdaq: ... the development and commercialization of high-performance enzymes, today announced ... Officer, will present at two upcoming conferences. ... present at the Second Annual Marcum LLP Microcap Conference ... Hotel in New York City.  The presentation is scheduled ...
(Date:5/23/2013)... May 23, 2013 SynCardia Systems, Inc. ... only FDA, Health Canada and CE (Europe) approved Total ... in Scotland, which boasts more than 380,000 visitors annually, ... powered by the Freedom® portable driver as part ... most advanced exhibitions of its kind. , “BodyWorks ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Bed bugs ... the university had already confirmed it. Meanwhile, My Cleaning Products ... bed bug victims fight the pests without using harmful chemical ... on May 15, 2013, the affected building was actually a ... being infested was said made on May 13 and bed ...
Breaking Biology Technology:NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 3Penn State Dorm Infested with Bed Bugs, My Cleaning Products Offers Complimentary Sample of Bed Bug Spray to Help Bed Bug Victims 2
... the National Institute of Standards and Technology (NIST) ... detecting and measuring elusive hazards such as concealed ... pesticides distributed in soil by wind and rain. ... techniques for detecting traces of these materials, which ...
... University Belfast are developing new sensors to detect chemical agents ... the threat of terrorist attacks. The devices will use ... to gather a sample which is then analysed by a ... seconds. This will allow better, faster decisions to be made ...
... , IRVINE, Calif., Nov. 18 ... CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, announced ... healthcare Group Purchasing Organizations (GPO) in France, has signed ... ® pulse oximeters. The agreement offers preferred ...
Cached Biology Technology:Prototype NIST method detects and measures elusive hazards 2New technology detects chemical weapons in seconds 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 4
(Date:5/22/2013)... engineers must join together in a major new effort ... crisis in providing Earth,s people with clean water that ... of a comment article in the current edition of ... of the American Chemical Society (ACS), the world,s largest ... Sedlak, Ph.D., and Jerald L. Schnoor, Ph.D., explain that ...
(Date:5/22/2013)... in cellular DNA can endanger the whole organism, as ... at Ludwig-Maximilians-Universitaet (LMU) in Munich now report how byproducts ... helix. , The DNA in our cells controls the ... bodies. The instructions for this are encoded in the ... the bases adenine (A), cytosine (C), guanine (G) and ...
(Date:5/22/2013)... the biodiversity of pollinating insects and wild plants have ... , Researchers led by the University of Leeds and ... evidence of dramatic reductions in the diversity of species ... and 1980s. , But the picture brightened markedly after ... losses among bees, hoverflies and wild plants. ...
Breaking Biology News(10 mins):DNA damage: The dark side of respiration 2Encouraging signs for bee biodiversity 2Encouraging signs for bee biodiversity 3
... People who inherit a specific form of a gene ... protected against some forms of cancer, according to a new ... The MET proto-oncogene is activated in a variety ... to autism and has a role in neurodevelopment, which is ...
... of researchers including scientists from the University of Florida has ... as individuals, a finding that suggests insect societies operate like ... cycle. For more than a century, biologists have marveled ... social insects that work together to determine the survival and ...
... 1. Prescribed Opioids Associated with Significant Risk for Overdose ... have increased significantly over the past decade. As long-term ... the deaths associated with opioids increase. Opioid overdose is ... sought to determine the rate of opioid overdose in ...
Cached Biology News:Gene linked to schizophrenia may reduce cancer risk 2Study suggests theory for insect colonies as 'superorganisms' 2Annals of Internal Medicine tip sheet for Jan. 19, 2010, issue 2Annals of Internal Medicine tip sheet for Jan. 19, 2010, issue 3
... IRsolution software provides quick and easy operation ... with Windows-based control. The software is ... FDA 21 CFR Part 11 regulations, and ... measurement. IRsolutions versatility enables use in ...
... kit provides reagents for immune complex disruption ... plasma samples using a combination of low ... neutralized and transferred to microplate wells which ... monoclonal antibody to HIV-1 p24. The immobilized ...
... an automated solution for scheduling, performing and ... for all pipettes and liquid handling devices. ... Supports all gravimetric calibration protocols ... ISO 9000, NCCLS and GLP requirements ...
... which belong to the transforming growth ... is a large group of extra-cellular ... of development, reproductive function and tumor ... bone morphogenetic proteins, growth differentiation factors, ...
Biology Products: